Skip to main content
Top
Published in: Acta Diabetologica 1/2024

20-09-2023 | Ketoacidosis | Original Article

Clinical profile of patients with diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome in Japan: a multicenter retrospective cohort study

Authors: Kyosuke Takahashi, Norimichi Uenishi, Masamitsu Sanui, Shigehiko Uchino, Naoki Yonezawa, Tetsuhiro Takei, Norihiro Nishioka, Hirotada Kobayashi, Shunichi Otaka, Kotaro Yamamoto, Hideto Yasuda, Shintaro Kosaka, Hidehiko Tokunaga, Naoki Fujiwara, Takashiro Kondo, Tomoki Ishida, Takayuki Komatsu, Koji Endo, Taiki Moriyama, Takayoshi Oyasu, Mineji Hayakawa, Atsumi Hoshino, Tasuku Matsuyama, Yuki Miyamoto, Akihiro Yanagisawa, Tadamasa Wakabayashi, Takeshi Ueda, Tetsuya Komuro, Toshiro Sugimoto, Alan Kawarai Lefor

Published in: Acta Diabetologica | Issue 1/2024

Login to get access

Abstract

Introduction

Diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar syndrome (HHS) are life-threatening complications of diabetes mellitus. Their clinical profiles have not been fully investigated.

Methods

A multicenter retrospective cohort study was conducted in 21 acute care hospitals in Japan. Patients included were adults aged 18 or older who had been hospitalized from January 1, 2012, to December 31, 2016 due to DKA or HHS. The data were extracted from patient medical records. A four-group comparison (mild DKA, moderate DKA, severe DKA, and HHS) was performed to evaluate outcomes.

Results

A total of 771 patients including 545 patients with DKA and 226 patients with HHS were identified during the study period. The major precipitating factors of disease episodes were poor medication compliance, infectious diseases, and excessive drinking of sugar-sweetened beverages. The median hospital stay was 16 days [IQR 10–26 days]. The intensive care unit (ICU) admission rate was 44.4% (mean) and the rate at each hospital ranged from 0 to 100%. The in-hospital mortality rate was 2.8% in patients with DKA and 7.1% in the HHS group. No significant difference in mortality was seen among the three DKA groups.

Conclusions

The mortality rate of patients with DKA in Japan is similar to other studies, while that of HHS was lower. The ICU admission rate varied among institutions. There was no significant association between the severity of DKA and mortality in the study population.

Trial Registration

This study is registered in the UMIN clinical Trial Registration System (UMIN000025393, Registered 23th December 2016).
Appendix
Available only for authorised users
Literature
8.
go back to reference Barski L, Nevzorov R, Rabaev E et al (2012) Diabetic ketoacidosis: clinical characteristics, precipitating factors and outcomes of care. Isr Med Assoc J 14:298–302 Barski L, Nevzorov R, Rabaev E et al (2012) Diabetic ketoacidosis: clinical characteristics, precipitating factors and outcomes of care. Isr Med Assoc J 14:298–302
21.
go back to reference Braatvedt G, Kwan A, Dransfield W et al (2019) Differing protocols of managing adult diabetic ketoacidosis outside of the intensive care unit make no difference to the rate of resolution of hyperglycaemia and acidosis. N Z Med J 132:13–23PubMed Braatvedt G, Kwan A, Dransfield W et al (2019) Differing protocols of managing adult diabetic ketoacidosis outside of the intensive care unit make no difference to the rate of resolution of hyperglycaemia and acidosis. N Z Med J 132:13–23PubMed
24.
Metadata
Title
Clinical profile of patients with diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome in Japan: a multicenter retrospective cohort study
Authors
Kyosuke Takahashi
Norimichi Uenishi
Masamitsu Sanui
Shigehiko Uchino
Naoki Yonezawa
Tetsuhiro Takei
Norihiro Nishioka
Hirotada Kobayashi
Shunichi Otaka
Kotaro Yamamoto
Hideto Yasuda
Shintaro Kosaka
Hidehiko Tokunaga
Naoki Fujiwara
Takashiro Kondo
Tomoki Ishida
Takayuki Komatsu
Koji Endo
Taiki Moriyama
Takayoshi Oyasu
Mineji Hayakawa
Atsumi Hoshino
Tasuku Matsuyama
Yuki Miyamoto
Akihiro Yanagisawa
Tadamasa Wakabayashi
Takeshi Ueda
Tetsuya Komuro
Toshiro Sugimoto
Alan Kawarai Lefor
Publication date
20-09-2023
Publisher
Springer Milan
Keyword
Ketoacidosis
Published in
Acta Diabetologica / Issue 1/2024
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-023-02181-1

Other articles of this Issue 1/2024

Acta Diabetologica 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.